BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30760720)

  • 1. Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
    Gay DM; Ridgway RA; Müller M; Hodder MC; Hedley A; Clark W; Leach JD; Jackstadt R; Nixon C; Huels DJ; Campbell AD; Bird TG; Sansom OJ
    Nat Commun; 2019 Feb; 10(1):723. PubMed ID: 30760720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
    Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
    Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
    Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
    EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
    de la Roche M; Worm J; Bienz M
    BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
    Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
    Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
    Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
    Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cited1 deficiency suppresses intestinal tumorigenesis.
    Méniel V; Song F; Phesse T; Young M; Poetz O; Parry L; Jenkins JR; Williams GT; Dunwoodie SL; Watson A; Clarke AR
    PLoS Genet; 2013; 9(8):e1003638. PubMed ID: 23935526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.
    Cantù C; Zimmerli D; Hausmann G; Valenta T; Moor A; Aguet M; Basler K
    Genes Dev; 2014 Sep; 28(17):1879-84. PubMed ID: 25184676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts.
    Leedham SJ; Rodenas-Cuadrado P; Howarth K; Lewis A; Mallappa S; Segditsas S; Davis H; Jeffery R; Rodriguez-Justo M; Keshav S; Travis SP; Graham TA; East J; Clark S; Tomlinson IP
    Gut; 2013 Jan; 62(1):83-93. PubMed ID: 22287596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
    Deka J; Wiedemann N; Anderle P; Murphy-Seiler F; Bultinck J; Eyckerman S; Stehle JC; André S; Vilain N; Zilian O; Robine S; Delorenzi M; Basler K; Aguet M
    Cancer Res; 2010 Aug; 70(16):6619-28. PubMed ID: 20682801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.
    Sakamaki A; Katsuragi Y; Otsuka K; Tomita M; Obata M; Iwasaki T; Abe M; Sato T; Ochiai M; Sakuraba Y; Aoyagi Y; Gondo Y; Sakimura K; Nakagama H; Mishima Y; Kominami R
    Carcinogenesis; 2015 Jun; 36(6):622-31. PubMed ID: 25827435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
    Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.
    Brack AS; Murphy-Seiler F; Hanifi J; Deka J; Eyckerman S; Keller C; Aguet M; Rando TA
    Dev Biol; 2009 Nov; 335(1):93-105. PubMed ID: 19699733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer.
    Yu T; Chen X; Zhang W; Colon D; Shi J; Napier D; Rychahou P; Lu W; Lee EY; Weiss HL; Evers BM; Liu C
    J Biol Chem; 2012 Feb; 287(6):3760-8. PubMed ID: 22170051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.